Mesothelioma Trial, Recruiting (NCT06637345)

Mesothelioma Trial, Recruiting NCT06637345 Sponsor: Centro di Riferimento Oncologico - Aviano Condition: Mesothelioma

Printed from Voxsanity (voxsanity.com.au) — NCT06637345 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Mesothelioma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You are able to understand, agree to, and sign a consent form
You have been diagnosed with malignant pleural mesothelioma (a type of cancer affecting the lining of the lungs) confirmed by a tissue sample test
You have previously received chemotherapy treatment
You have previously had a limited surgical procedure, such as a diagnostic keyhole operation on the chest or surgery that did not remove all of the cancer
You are considered suitable for, or have already received, a course of radiation therapy to one side of the chest (at a specific dose level, confirm details with trial site)

Who may not be able to join:

Your cancer diagnosis has not been confirmed through a tissue sample test
The way your cancer has spread means that radiation treatment would not be a suitable option (confirm with trial site)
Your cancer had already spread to other parts of the body at the time of your original diagnosis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alberto Revelant, MD, Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS

Phone: 0434 659 159

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06637345

Sponsor: Centro di Riferimento Oncologico - Aviano

Phase: Not Applicable

Status: Recruiting

Condition: Mesothelioma

Trial contact: 0434 659 159

More information: https://clinicaltrials.gov/study/NCT06637345

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You are able to understand, agree to, and sign a consent form
You have been diagnosed with malignant pleural mesothelioma (a type of cancer affecting the lining of the lungs) confirmed by a tissue sample test
You have previously received chemotherapy treatment
You have previously had a limited surgical procedure, such as a diagnostic keyhole operation on the chest or surgery that did not remove all of the cancer
You are considered suitable for, or have already received, a course of radiation therapy to one side of the chest (at a specific dose level, confirm details with trial site)

Who may not be able to join:

Your cancer diagnosis has not been confirmed through a tissue sample test
The way your cancer has spread means that radiation treatment would not be a suitable option (confirm with trial site)
Your cancer had already spread to other parts of the body at the time of your original diagnosis

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centro di Riferimento Oncologico - Aviano

Registry

ClinicalTrials.gov

Start date

15 March 2024

Est. completion

15 March 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Association between biomarker levels measured at the end of radiation treatment and pulmonary toxicity of grade ≥2 associated with RT developed as an acute (within 6 months) or late (after 6 months) event

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov